Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND
NCT05295732Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of TMB-001 in congenital ichthyosis, sponsored by LEO Pharma. Started Jun 2022; status: completed.
02
Drugs
TMB-001
03
Conditions
congenital ichthyosis
Beyond the preview
Go deeper on NCT05295732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05295732.